Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the
development of revolutionary bone grafts and coatings for medical
applications, today announced that its CEO, Dan Goldberger, and CFO,
John Gandolfo, will present at the Leerink Global Healthcare Conference,
to be held February 12-13, 2014 at the Waldorf Astoria Hotel in New
York. Bacterin's presentation will take place Thursday February 13, 2014
at 3:30 PM EST.
A live broadcast of the conference presentation will be available. To
access the broadcast, go to the "Investor Info" section of the Company's
website at www.bacterin.com.
A replay of the conference presentation will also be available.
About Bacterin International Holdings
Bacterin International Holdings, Inc. (NYSE MKT: BONE) develops,
manufactures and markets biologics products to domestic and
international markets. These products are used in a variety of
applications including enhancing fusion in spine surgery, relief of back
pain, promotion of bone growth in foot and ankle surgery, promotion of
cranial healing following neurosurgery and subchondral repair in knee
and other joint surgeries.
Bacterin's Medical Device division develops, employs, and licenses
coatings for various medical device applications. For further
information, please visit www.bacterin.com.
[ Back To NFVZone's Homepage ]